Psychemedics Performance
| PMDDelisted Stock | USD 2.67 0.06 2.30% |
On a scale of 0 to 100, Psychemedics holds a performance score of 7. The company holds a Beta of -0.62, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Psychemedics are expected to decrease at a much lower rate. During the bear market, Psychemedics is likely to outperform the market. Please check Psychemedics' kurtosis, and the relationship between the downside variance and day median price , to make a quick decision on whether Psychemedics' historical price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Psychemedics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, Psychemedics exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 4.8 M |
Psychemedics |
Psychemedics Relative Risk vs. Return Landscape
If you would invest 232.00 in Psychemedics on November 2, 2024 and sell it today you would earn a total of 35.00 from holding Psychemedics or generate 15.09% return on investment over 90 days. Psychemedics is generating 0.7683% of daily returns assuming volatility of 8.0526% on return distribution over 90 days investment horizon. In other words, 71% of pink sheets are less volatile than Psychemedics, and above 85% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Psychemedics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Psychemedics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Psychemedics, and traders can use it to determine the average amount a Psychemedics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0954
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.05 actual daily | 71 71% of assets are less volatile |
Expected Return
| 0.77 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Psychemedics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Psychemedics by adding it to a well-diversified portfolio.
Psychemedics Fundamentals Growth
Psychemedics Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Psychemedics, and Psychemedics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Psychemedics Pink Sheet performance.
| Return On Equity | -0.61 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | (0.22) % | |||
| Operating Margin | (0.19) % | |||
| Current Valuation | 14.22 M | |||
| Shares Outstanding | 5.89 M | |||
| Price To Earning | 92.08 X | |||
| Price To Book | 2.58 X | |||
| Price To Sales | 0.76 X | |||
| Revenue | 22.1 M | |||
| EBITDA | (251 K) | |||
| Cash And Equivalents | 1.79 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 2.3 M | |||
| Debt To Equity | 0.36 % | |||
| Book Value Per Share | 1.15 X | |||
| Cash Flow From Operations | (1.48 M) | |||
| Earnings Per Share | (0.51) X | |||
| Total Asset | 12.33 M | |||
| Retained Earnings | (16.77 M) | |||
| Current Asset | 8.46 M | |||
| Current Liabilities | 3.56 M | |||
About Psychemedics Performance
By analyzing Psychemedics' fundamental ratios, stakeholders can gain valuable insights into Psychemedics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Psychemedics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Psychemedics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts. Psychemedics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.Things to note about Psychemedics performance evaluation
Checking the ongoing alerts about Psychemedics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Psychemedics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Psychemedics is not yet fully synchronised with the market data | |
| Psychemedics is way too risky over 90 days horizon | |
| Psychemedics appears to be risky and price may revert if volatility continues | |
| Psychemedics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 22.1 M. Reported Net Loss for the year was (4.15 M) with profit before taxes, overhead, and interest of 9.29 M. | |
| Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Psychemedics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Psychemedics' stock is overvalued or undervalued compared to its peers.
- Examining Psychemedics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Psychemedics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Psychemedics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Psychemedics' pink sheet. These opinions can provide insight into Psychemedics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Psychemedics Pink Sheet
If you are still planning to invest in Psychemedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Psychemedics' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |